Functional antibody responses to SARS-CoV-2 variants before and after booster vaccination among adults in Ghana

QR Code

Functional antibody responses to SARS-CoV-2 variants before and after booster vaccination among adults in Ghana

COVID-19 booster vaccinations are needed to enhance waning immunity and the emergence of new variants. In Africa, where COVID-19 vaccine coverage is low, there is a paucity of data on COVID-19 vaccine-induced immunity, particularly in the post-omicron era. This study examined the functional activity...

Full description

Saved in:

Bibliographic Details
Main Authors:	F. D. Partey, A. N. A. Pobee, I. K. Damptey, F. Osei, M. M. A. K. Owusu-Amponsah, Y. A. A. Ansah, C. Ye, S. Bradfute, I. Hurwitz, P. K. Quashie, M. F. Ofori, A. K. Kusi, D. J. Perkins, G. A. Awandare
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Experimental Biology and Medicine
Subjects:	COVID-19 vaccination COVID-19 booster SARS-CoV-2 booster vaccination COVID-19
Online Access:	https://www.ebm-journal.org/articles/10.3389/ebm.2025.10440/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Perception of COVID-19 Vaccination Based on Health Belief Model and the Acceptance of COVID-19 Booster Vaccination
by: Risma Arlyani Dewi, et al.
Published: (2023-04-01)

COVID Arm After Moderna Booster in Healthcare Worker: A Case Report
by: Anshari Saifuddin, et al.
Published: (2021-10-01)

Booster vaccination against the SARS-CoV-2: mechanisms and efficiency
by: S. A. Berns, et al.
Published: (2023-12-01)

Neutralizing antibody response to different COVID-19 vaccines in Brazil: the impact of previous infection and booster doses
by: Beatriz L. L. Caetano, et al.
Published: (2025-08-01)

Modeling the potential public health and economic impact of different COVID-19 booster dose vaccination strategies with an adapted vaccine in the United Kingdom
by: Cale Harrison, et al.
Published: (2024-12-01)

Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis
by: Alberto San Francisco Ramos, et al.
Published: (2024-12-01)

Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan
by: Mitsuhiro Nagano, et al.
Published: (2024-12-01)

Safety and immunogenicity of booster doses of an XBB.1.5 RBD subunit COVID-19 vaccine among individuals aged 5–80 years in India: a phase 3, single-blind, randomised controlled trialResearch in context
by: Subhash Thuluva, et al.
Published: (2025-09-01)

Modelling the Potential Public Health Impact of Different COVID-19 Vaccination Strategies with an Adapted Vaccine in Singapore
by: Karan Thakkar, et al.
Published: (2024-12-01)

Modeling the potential public health impact of different vaccination strategies with an adapted vaccine in South Africa
by: Nadine Al Akoury, et al.
Published: (2024-12-01)

COVID-19 Vaccine Timing and Co-Administration with Influenza Vaccines in Canada: A Systematic Review with Comparative Insights from G7 Countries
by: Farah Al hashimi, et al.
Published: (2025-06-01)

5-Aminolevulinic Acid Phosphate as an Immune System Enhancer Along with Vaccination Against SARS-CoV-2 Virus Infection: An Open-Label, Randomized Pilot Study
by: Norbert Berenzen, et al.
Published: (2025-06-01)

The interdisciplinary Meeting of Experts’s Resolution «Unresolved Questions of Pertussis Epidemiology in the Russian Federation and the New Possibilities for Vaccination»
by: Article Editorial
Published: (2018-09-01)

A descriptive review on the real-world impact of Moderna, Inc. COVID-19 vaccines
by: Mary Bausch-Jurken, et al.
Published: (2024-12-01)

Understanding COVID-19 booster information seeking in a collectivist context: the roles of social expectations, trust in experts, and uncertainty
by: Xiaoshan Austin Li, et al.
Published: (2025-07-01)

A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children
by: Frances Priddy, et al.
Published: (2024-12-01)

COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?
by: Siti Setiati, et al.
Published: (2021-03-01)

Impact of vaccination status on the clinical course and outcomes of acute COVID-19 period: data from the international registry "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors" (AKTIV-4)
by: G. P. Arutyunov, et al.
Published: (2025-04-01)

Influenza and Pneumococcal Vaccination of Healthcare Workers during a Pandemic Reduces the Risk and Severity of COVID-19 in Vaccinated
by: M. P. Kostinov, et al.
Published: (2023-09-01)

Evaluating vaccination dosing strategies for SARS-CoV-2 in patients at high-risk for allergic reactions: Insights from vaccination campaign
by: Stefania Nicola, MD, et al.
Published: (2025-08-01)

The Control of Fluxes of Electric Power in Networks by Means of Phase-switching Booster Transformers
by: Govorov F.P., et al.
Published: (2016-12-01)

Awareness and Acceptance of COVID-19 Vaccine Uptake among Adults in Lagos State, Nigeria
by: Fasoranti Afolabi Joseph
Published: (2021-11-01)

Evidence for a 10-year TBE vaccine booster interval: an evaluation of current data
by: Jörg Schelling, et al.
Published: (2024-12-01)

The effectiveness of vaccination and booster vaccinations against new coronavirus infection in real practice
by: K. K. Tikhomirova, et al.
Published: (2024-09-01)

Current epidemiological characteristics of pertussis in the Russian Federation
by: A. V. Stepenko, et al.
Published: (2020-06-01)

Aspects and issues of marketing authorisation and use of medicinal products for COVID-19 prevention during the pandemic
by: A. A. Soldatov, et al.
Published: (2022-12-01)

Post COVID-19 Immunization Herpes Zoster Reactivation In Asia : A Literature Review
by: Nurul Nisa Ulfa, et al.
Published: (2023-07-01)

Specificity of COVID-19 in patients undergoing maintenance hemodialysis
by: Brković Voin, et al.
Published: (2025-01-01)

Formation Features of the Natural and Post-Vaccination Anti-Diphtheria Antitoxic Immunity
by: E. A. Shmeleva, et al.
Published: (2021-03-01)

COVID-19 Vaccines: Current Status and Implication for Use in Indonesia
by: Youdiil Ophinni, et al.
Published: (2020-12-01)

COVID-19 Vaccines: Current Status and Implication for Use in Indonesia
by: Youdiil Ophinni, et al.
Published: (2020-12-01)

Effect of COVID 19 vaccination on the CT severity score for SARS CoV2 pneumonia- an experience from the initial wave.
by: Radhika Batra, et al.
Published: (2023-07-01)

The Impact of Immunization with Anti-Coronavirus Vaccines on the Incidence of COVID-19 in Employees of a Large Tuberculosis Institution in Moscow
by: E. M. Bogorodskaya, et al.
Published: (2022-05-01)

PERTUSSIS — INFECTION NOT UNDER COMPLETE CONTROL
by: V. K. Tatochenko
Published: (2014-03-01)

Assessing breakthrough infections: Covishield (late schedule) versus Covaxin - A prospective comparative analysis in the general population
by: Anuradha Nadda, et al.
Published: (2025-06-01)

Post-Vaccination Immunity to Pertussis in Children of Lipetsk, New Management Capabilitiesto Infection
by: T. V. Timofeeva, et al.
Published: (2019-06-01)

Enablers and Barriers of COVID-19 Vaccination in the Philippines
by: Evalyn Roxas, et al.
Published: (2025-07-01)

COVID-19 vaccination status and factors associated with deaths from the disease, Vitória, 2020-2023: cross-sectional study
by: Tatiane Comerio, et al.
Published: (2025-07-01)

Cardiopulmonary Effects of COVID-19 Vaccination: A Comprehensive Narrative Review
by: Lauren T. Forchette, et al.
Published: (2025-05-01)

Communication in the health area of Argentina in times of Covid-19 pandemic
by: K. Ramacciotti, et al.
Published: (2022-12-01)